Asparaginase Erwinia Chrysanthemi Injection Uses, Dosage, Side Effects and Interactions
Erwinaze
Erwinaze is a brand name for asparaginase erwinia chrysanthemi injection. It is not in the FDA’s directory today.
Rylaze
Rylaze is a brand of asparaginase erwinia chrysanthemi injection that comes as an injection.
Asparaginase erwinia chrysanthemi (Rylaze) is an injected enzyme medicine used with other chemotherapy to treat acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in people who became allergic to E. coli-derived asparaginase.
Quick links
Ask Anything About Asparaginase Erwinia Chrysanthemi InjectionType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Asparaginase Erwinia Chrysanthemi Injection in Short
- Drug class Asparagine-specific Enzyme How the FDA classifies it
What it treatsRylaze is used as one part of a multi-agent chemotherapy regimen. It treats acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL). It is for adults and children 1 month or older who developed hypersensitivity (an allergic-type reaction) to E. coli-derived asparaginase.
- How you get it Prescription only
- Comes asInjection (into a muscle)
- Important safety informationWarnings and precautions Read the warnings and precautions for your exact product.
The Pharmacist’s Take
Rylaze is an injected enzyme that clears asparagine, an amino acid some leukemia cells cannot make themselves, from the blood. It is the backup asparaginase in chemotherapy for acute lymphoblastic leukemia and lymphoblastic lymphoma once someone becomes allergic to the E. coli-derived kind, and it has been on the market since about 2021 with no generic version. It is a demanding medicine, and people often notice nausea, tiredness and achy muscles and joints, while liver blood tests commonly drift out of range. Watch most closely for an allergic reaction, which is fairly common, and for severe stomach pain or vomiting, which can mean pancreatitis (an inflamed pancreas).
Key Takeaways From the HelloPharmacist Team
- Plan on clinic visits for a shot into a muscle, every 48 hours or on a Monday, Wednesday and Friday schedule.
- Expect medicines 30 to 60 minutes before each shot to blunt allergic reactions, and get help immediately for hives, swelling or trouble breathing.
- Count on regular liver and blood sugar tests, and call about yellowing skin or eyes, a sudden severe headache or unusual bleeding.
- Call your care team for any fever or sign of infection, since this treatment can leave white blood cell counts low.
Patient Information Guide for Asparaginase Erwinia Chrysanthemi Injection
What It’s Used For
Rylaze is used as part of combination chemotherapy for these conditions:
- Acute lymphoblastic leukemia (ALL)
- Lymphoblastic lymphoma (LBL)
- Rylaze is for adults and children 1 month or older who developed hypersensitivity to E. coli-derived asparaginase.
How It Works
Rylaze is an enzyme that turns the amino acid asparagine into aspartic acid and ammonia. This lowers asparagine in the blood.
Some leukemia cells make very little asparagine themselves and depend on the blood supply. Without it, those cells die.
Drug Class
Drug Class
- Asparagine-specific Enzyme
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)- Asparagine-specific Enzyme
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)None listed for Asparaginase Erwinia Chrysanthemi Injection in the FDA’s index.
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)None listed for Asparaginase Erwinia Chrysanthemi Injection in the FDA’s index.
From our Patient Information GuideRylaze is an enzyme that turns the amino acid asparagine into aspartic acid and ammonia. This lowers asparagine in the blood. Some leukemia cells make very little asparagine themselves and depend on the blood supply. Read How Asparaginase Erwinia Chrysanthemi Injection Works
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)- Asparaginase
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Other antineoplastic agents
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
Rylaze is injected into a muscle by a health care professional. It replaces a long-acting asparaginase product, using either an every-48-hours schedule or a Monday/Wednesday/Friday schedule.
- Doses are based on body size, and large doses may be split among several injection sites.
- You get premedication 30 to 60 minutes before to lower allergic reaction risk.
- Blood tests, including liver tests and blood sugar, are checked regularly.
Your care team handles scheduling, so follow their directions.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
ALL or LBL, replacing a long-acting asparaginase, rylaze every 48 hours
Usual dose 25 mg/m2 injected into a muscle every 48 hours
- 25 mg/m2 intramuscularly every 48 hours
ALL stands for acute lymphoblastic leukemia.
LBL stands for lymphoblastic lymphoma.
ALL or LBL, replacing a long-acting asparaginase, rylaze on a Monday/Wednesday/Friday schedule
Usual dose 25 mg/m2 into a muscle on Monday and Wednesday mornings, 50 mg/m2 on Friday afternoon
- 25 mg/m2 intramuscularly on Monday morning and Wednesday morning, and 50 mg/m2 intramuscularly on Friday afternoon
- Give the Friday afternoon dose 53 to 58 hours after the Wednesday morning dose
ALL stands for acute lymphoblastic leukemia.
LBL stands for lymphoblastic lymphoma.
Replacing one dose of calaspargase pegol products, 25 mg/m2 every 48 hours
11 doses of RylazeReplacing one dose of pegaspargase products, 25 mg/m2 every 48 hours
7 doses of RylazeReplacing one dose of calaspargase pegol products, Monday/Wednesday/Friday 25/25/50 mg/m2
9 doses of RylazeReplacing one dose of pegaspargase products, Monday/Wednesday/Friday 25/25/50 mg/m2
6 doses of Rylaze
Side Effects
Common side effects seen with Rylaze plus chemotherapy include:
Common side effects
- Abnormal liver blood tests
- Nausea
- Muscle and joint pain
- Infection
- Tiredness
- Headache
- Fever with low white blood cell count (febrile neutropenia)
- Bleeding or bruising
- Mouth sores, belly pain, decreased appetite, diarrhea, high blood sugar and low potassium
When to get medical help
- Get help right away for signs of a serious allergic reaction, such as swelling of the lips, face or eyes, hives, trouble breathing, wheezing, or a drop in blood pressure.
- Call your care team for symptoms of pancreatitis (inflammation of the pancreas), such as severe stomach pain, nausea or vomiting.
- Seek help for signs of a blood clot, such as sudden severe headache, chest pain or shortness of breath.
- Report serious or unusual bleeding.
- Report signs of liver problems, including rapid weight gain, fluid buildup in the belly, painful liver enlargement, or yellowing of the skin or eyes.
- Tell your team about any fever or signs of infection.
Warnings and Precautions
- Allergic reactions: These can be severe, including anaphylaxis. Treatment is stopped permanently for serious reactions.
- Pancreatitis: Can be fatal if untreated. Rylaze is held or stopped depending on severity.
- Blood clots: Serious clots such as pulmonary embolism occurred in 1% of patients.
- Bleeding: Reported in 25% of patients and severe in 2%.
- Liver toxicity: Includes hepatic veno-occlusive disease. Liver tests are checked at least weekly during treatment cycles.
Before You Start
- Not for people with a prior serious allergic reaction to Erwinia asparaginase.
- Not for people with a history of serious pancreatitis, clots or bleeding on earlier asparaginase therapy.
- Not for severe liver impairment.
- Can harm an unborn baby. Pregnancy testing is recommended first.
- Use effective non-hormonal birth control during treatment and for 3 months after the last dose.
- Do not breastfeed during treatment and for 1 week after the last dose.
- Not established in children younger than 1 month.
- Not enough data in people 65 and older.
Half-Life and How Your Body Processes It
After an intramuscular injection, Rylaze reaches its peak level in a median of about 12 hours. Its apparent half-life is about 16 hours. It is expected to be broken down into small peptides. Black or African American patients had 29% lower clearance, which may raise drug exposure. The effects of kidney or liver impairment have not been studied.
Storage
Store RYLAZE vials refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Asparaginase Erwinia Chrysanthemi Injection Drug Interactions
Asparaginase Erwinia Chrysanthemi Injection: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Asparaginase Erwinia Chrysanthemi Injection — the kind of thing our pharmacy team would talk through with you at the counter.
What is Rylaze used for?
How is Rylaze given?
What side effects should I expect?
When should I get urgent help?
Can I use Rylaze during pregnancy or while breastfeeding?
What happens if I miss a dose of Rylaze?
Is asparaginase erwinia chrysanthemi injection available over the counter?
When was asparaginase erwinia chrysanthemi injection first available?
What is the brand name of asparaginase erwinia chrysanthemi injection?
What is the generic name of Erwinaze?
What drug class is asparaginase erwinia chrysanthemi injection?
What strengths does asparaginase erwinia chrysanthemi injection come in?
Where can I read the asparaginase erwinia chrysanthemi injection prescribing information (package insert)?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Asparaginase Erwinia Chrysanthemi Injection
Skip the scrolling. Ask in your own words and get an answer from Asparaginase Erwinia Chrysanthemi Injection’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Asparaginase Erwinia Chrysanthemi Injection’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Asparaginase Erwinia Chrysanthemi Injection on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, usually within a day.Asparaginase Erwinia Chrysanthemi Injection Forms and Strengths (How It Comes)
Asparaginase Erwinia Chrysanthemi Injection comes in 1 dose form, the injection. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Asparaginase Erwinia Chrysanthemi Injection inactive ingredients by manufacturer.
Injection
How this form is used
- Rylaze is used with other chemotherapy to treat acute lymphoblastic leukemia and lymphoblastic lymphoma in people 1 month or older who became allergic to E. coli-derived asparaginase.
- Rylaze is given by injection into a muscle, with injection sites rotated.
- Rylaze should not be injected into scarred, reddened, inflamed or swollen skin.
- Rylaze is given after premedication to lower the risk of allergic reactions.
- Rylaze is given where anaphylaxis can be treated right away.
Asparaginase Erwinia Chrysanthemi Injection on the U.S. Market: Products, Makers and Brands
How Asparaginase Erwinia Chrysanthemi Injection appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
1 company lists 1 Asparaginase Erwinia Chrysanthemi Injection product record with the FDA, mostly as injection; the earliest marketing or approval year on record is 2021. The one brand name in the directory today is Rylaze; the rest are generics.
Also listed with the FDA, not a patient dose form: Unfinished injection (1) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
How Widely Asparaginase Erwinia Chrysanthemi Injection Is Used (Medicaid Data)
How many Asparaginase Erwinia Chrysanthemi Injection prescriptions Medicaid paid for in Q2 2025 – Q1 2026, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Asparaginase Erwinia Chrysanthemi Injection prescribed? Of the 1,682 medications we measure, Asparaginase Erwinia Chrysanthemi Injection ranks #1,296 by Medicaid prescriptions — more than 23% of them.
Source: Medicaid State Drug Utilization Data (CMS), all states. 1 of the 2 listed Asparaginase Erwinia Chrysanthemi Injection NDCs had Medicaid claims.
Compare Asparaginase Erwinia Chrysanthemi Injection Products
A representative set of FDA-listed product records for Asparaginase Erwinia Chrysanthemi Injection — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Injection | ||||
| 20 mg/mL | Intramuscular | Jazz Pharmaceuticals, Inc. | BLA | View NDC → |
Showing 1 of 1 products — FDA National Drug Code Directory. See every product, package size and price: browse all 1 Asparaginase Erwinia Chrysanthemi Injection NDCs →
Asparaginase Erwinia Chrysanthemi Injection Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Asparaginase Erwinia Chrysanthemi Injection — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Asparaginase Erwinia Chrysanthemi Injection in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Asparaginase Erwinia Chrysanthemi Injection FDA Approval History
How Asparaginase Erwinia Chrysanthemi Injection went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Asparaginase Erwinia Chrysanthemi Injection Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Asparaginase Erwinia Chrysanthemi recalls since July 2021.
✅No Asparaginase Erwinia Chrysanthemi recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Asparaginase Erwinia Chrysanthemi Injection Supply and Shortage Status
Whether Asparaginase Erwinia Chrysanthemi Injection is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
Asparaginase Erwinia Chrysanthemi Injection Brand Names
Asparaginase Erwinia Chrysanthemi Injection has 2 brand names on record: Erwinaze and Rylaze. Rylaze is in the FDA’s product directory today; Erwinaze is not. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Asparaginase Erwinia Chrysanthemi Injection: Manufacturers and Labelers
One company lists Asparaginase Erwinia Chrysanthemi Injection products with the FDA. By number of product records, the largest are Jazz Pharmaceuticals, Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Asparaginase Erwinia Chrysanthemi Injection Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Jazz Pharmaceuticals, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →